Osimertinib with Chemotherapy in EGFR-Mutated NSCLC. Reply. David Planchard,Pasi A Jänne,Kunihiko KobayashiThe New England journal of medicine(2024)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要